Package 82009-104-05

{"route": ["ORAL"], "spl_id": "c628bc60-920f-4d54-b41e-820aaccff112", "openfda": {"unii": ["JQT35NPK6C"], "rxcui": ["312440", "312441", "317573"], "spl_set_id": ["0331400c-b163-4856-bfb0-965470247cb3"], "manufacturer_name": ["QUALLENT PHARMACEUTICALS HEALTH LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (82009-104-05)", "package_ndc": "82009-104-05", "marketing_start_date": "20230801"}], "brand_name": "PIOGLITAZONE HYDROCHLORIDE", "product_id": "82009-104_c628bc60-920f-4d54-b41e-820aaccff112", "dosage_form": "TABLET", "pharm_class": ["Peroxisome Proliferator Receptor alpha Agonist [EPC]", "Peroxisome Proliferator Receptor gamma Agonist [EPC]", "Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]", "Peroxisome Proliferator-activated Receptor gamma Agonists [MoA]", "Thiazolidinedione [EPC]", "Thiazolidinediones [CS]"], "product_ndc": "82009-104", "generic_name": "pioglitazone hydrochloride", "labeler_name": "QUALLENT PHARMACEUTICALS HEALTH LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PIOGLITAZONE HYDROCHLORIDE", "active_ingredients": [{"name": "PIOGLITAZONE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA200268", "marketing_category": "ANDA", "marketing_start_date": "20230801", "listing_expiration_date": "20261231"}